Skip to main content

Fiscal Wizard · Single-issue tearsheet

PEN / Jun 21, 2026 Run #7315

PEN

Penumbra, Inc.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Composite verdict

B 73.6 / 100
Bullish setup · Mean Reversion 10 drivers · 3 gates blocking
  • Commodity Channel Index
  • Connors RSI(2)
  • Stochastic Cross
Consider long call target Δ ~0.60 · ~35 DTE Bullish setup, Grade B → ITM call target

Industry rank 8th of 141 in Medical Devices

rescore-sweep
Technical synthesisRegime: range
Bull 100%Evidence: High · 14 signals0% Bear
Momentum Neutral 50Mean-reversion Bullish 93

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -87%
Asset value $36.30Earnings power value $45.48Price $317.20

Priced above its no-growth earnings power value ($45.48/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Mixed

47.6 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
EPS Growth (YoY) 100
Margin of Safety 0
Cash Conversion 97
Earnings Yield 0
Return on Assets 77
Inventory Turnover 0

Technicals Bullish

99.5 / 100

Bullish setup leads (Commodity Channel Index, Connors RSI(2), Stochastic Cross); bears gated by guards. · 43 signals shown.

Strongest
Weakest
Commodity Channel Index 91
Stochastic Cross 88
Connors RSI(2) 88

Risk Gates

3 blocking 4 caution

3 guards active, 27 signals gated.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

Realized Volatility Regime Blocking

High-vol regime mutes mean-reversion signals; low-vol regime mutes breakout signals.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for PEN.